Article Image
News Link • Healthcare Industry

Diabetes Drug Maker Hid Test Data on Risks, Files Indicate

• NY Times
In the fall of 1999, the drug giant SmithKline Beecham secretly began a study to find out if its diabetes medicine, Avandia, was safer for the heart than a competing pill, Actos, made by Takeda. 
Avandia’s success was crucial to SmithKline, whose labs were otherwise all but barren of new products.

Join us on our Social Networks:


Share this page with your friends on your favorite social network: